Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

TAMPA, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of

GlobeNewswireJun 17 16:10 ET

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

Commences the study, The Safety of Telomir-1 when Administered Orally to Geriatric Laboratory Beagle Dogs for 63 Consecutive Days study to evaluate the safety of Telomir-1 on geriatric canines Began geriatric canine

GlobeNewswireMay 30 08:30 ET

New to The Street TV Announces Episode 575 With Its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET

NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces broadcasting of its national business show that will air as a sponsored program on Bloomberg TV on Saturday, May 25, 2024, at 6:30

GlobeNewswireMay 24 09:30 ET

Telomir Pharmaceuticals, Inc. Signs Media Deal With New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support

NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- FMW Media Works' New to The Street televised business show will feature Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ($TELO) ("Company"), a pre-clinical stage

GlobeNewswireMay 16 09:30 ET

Telomir Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 16:36 ET · Announcements

Telomir Pharmaceuticals Sees Breakthrough Potential in Anti-Aging Treatment With Telomir 1 | NASDAQ:TELO

Proactive InvestorsMay 7 10:52 ET